N@N

ZOLL LifeVest Prescribed by Physicians at All U.S. News and World Report aHonor Rolla Hospitals and All 50 aBest Heart and Hear

^{Published on 2010-10-28 16:05:39 - Market Wire}
 

CHELMSFORD, Mass.--([ BUSINESS WIRE ])--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 14 aHonor Rolla hospitals and all of the 50 aBest Heart and Heart Surgerya hospitals designated by U.S. News and World Report for 2010-2011 have prescribed the ZOLL [ LifeVest^® ]Wearable Defibrillator for patients.

"We believe that the use of the LifeVest to treat patients at risk of sudden cardiac arrest at these premier institutions is an important indication of continued acceptance of the device as a standard of care"

The LifeVest is worn by patients at risk of sudden cardiac arrest (SCA), allowing their physicians time to assess their long-term arrhythmic risk and make appropriate plans. The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. The LifeVest does not require bystander intervention and has a 98 percent first treatment shock success rate for resuscitating patients with SCA.

aWe believe that the use of the LifeVest to treat patients at risk of sudden cardiac arrest at these premier institutions is an important indication of continued acceptance of the device as a standard of care,a said Richard A. Packer, Chief Executive Officer of ZOLL.

The LifeVest is used for a wide range of patient conditions, including following a heart attack, before or after bypass surgery or stent placement, as well as cardiomyopathy or congestive heart failure that places patients at particular risk. To date, the LifeVest has been prescribed to more than 30,000 patients. For more information, go to [ www.zoll.com ] or 1.800.543.3267.

[ U.S. News and World Reporta™s ]aAmericaa™s Best Hospitals,a is an annual ranking of the countrya™s elite medical centers that assesses how well a hospital handles complex and demanding situations. From among the 4,852 hospitals considered for the report, only 152 were ranked in one or more of the 16 specialties, and from those, only 14 qualified for the aHonor Rolla designation by earning high scores in at least six specialties. U.S. News and World Report also named the 50 aBest Heart and Heart Surgerya hospitals for 2010-2011 based on rankings within the specific category.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit [ www.zoll.com ].

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are aforward-lookinga statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled aRisk Factorsa in the Company'sQuarterlyReport on Form 10-Q filed with the SEC on August 11, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2010 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. LifeVest and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.